云南中医学院学报
雲南中醫學院學報
운남중의학원학보
JOURNAL OF YUNNAN COLLEGE OF TRADITIONAL CHINESE MEDICINE
2014年
1期
67-69
,共3页
刘俊%杨龄%刘滢%陈好远%温伟波
劉俊%楊齡%劉瀅%陳好遠%溫偉波
류준%양령%류형%진호원%온위파
健肝消脂颗粒%非酒精性脂肪肝%胰岛素抵抗
健肝消脂顆粒%非酒精性脂肪肝%胰島素牴抗
건간소지과립%비주정성지방간%이도소저항
Liver-invigorating and fat-reducing particles%nonalcoholic fatty liver disease%insulin resistance
目的:主要研究健肝消脂颗粒治疗NAFLD胰岛素抵抗的疗效。方法将患者分为治疗组与对照组,观察分析两者IR,ALT、AST、GGT,TG、TC、LDL-C,WC、BW、BMI的改善情况。结果1.两组IRI变化程度的差异有显著性意义(P<0.01),治疗组显著优于对照组。2.两组ALT、AST、GGT下降的差异无统计学意义(P>0.05)。3.两组TG、TC下降的差异有显著性意义(P<0.01),LDL-C下降的差异无统计学意义(P>0.05),治疗组显著优于对照组。4.两组WC下降的差异有统计学意义(P<0.05),BW下降的差异无统计学意义(P>0.05),BMI下降的差异有显著性意义(P<0.01),治疗组优于对照组。结论健肝消脂颗粒可以有效治疗NAFLD,可以改善其IR,可以降低ALT、AST、GGT,TG、TC,WC、BMI水平。
目的:主要研究健肝消脂顆粒治療NAFLD胰島素牴抗的療效。方法將患者分為治療組與對照組,觀察分析兩者IR,ALT、AST、GGT,TG、TC、LDL-C,WC、BW、BMI的改善情況。結果1.兩組IRI變化程度的差異有顯著性意義(P<0.01),治療組顯著優于對照組。2.兩組ALT、AST、GGT下降的差異無統計學意義(P>0.05)。3.兩組TG、TC下降的差異有顯著性意義(P<0.01),LDL-C下降的差異無統計學意義(P>0.05),治療組顯著優于對照組。4.兩組WC下降的差異有統計學意義(P<0.05),BW下降的差異無統計學意義(P>0.05),BMI下降的差異有顯著性意義(P<0.01),治療組優于對照組。結論健肝消脂顆粒可以有效治療NAFLD,可以改善其IR,可以降低ALT、AST、GGT,TG、TC,WC、BMI水平。
목적:주요연구건간소지과립치료NAFLD이도소저항적료효。방법장환자분위치료조여대조조,관찰분석량자IR,ALT、AST、GGT,TG、TC、LDL-C,WC、BW、BMI적개선정황。결과1.량조IRI변화정도적차이유현저성의의(P<0.01),치료조현저우우대조조。2.량조ALT、AST、GGT하강적차이무통계학의의(P>0.05)。3.량조TG、TC하강적차이유현저성의의(P<0.01),LDL-C하강적차이무통계학의의(P>0.05),치료조현저우우대조조。4.량조WC하강적차이유통계학의의(P<0.05),BW하강적차이무통계학의의(P>0.05),BMI하강적차이유현저성의의(P<0.01),치료조우우대조조。결론건간소지과립가이유효치료NAFLD,가이개선기IR,가이강저ALT、AST、GGT,TG、TC,WC、BMI수평。
Objective The main purpose is to research the curative effect of the liver-invigorating and fat-reducing particles to the insulin resistance of nonalcoholic fatty liver disease. Methods Take patients into two groups,to observe curative effect between two groups,to analyze the reducing of insulin resistance,ALT,AST,GGT,TG,TC,LDL-C,WC,BW,BMI. Results 1. The difference between two groups′ reducing extent of IRI is significant (P<0.01),treatment group is much better than control group. 2. The difference between two groups′ reducing extent of ALT,AST and GGT (P>0.05)are not statistically significant. 3. The difference between two groups′reducing extent of TG,TC are significant (P<0.01),and the difference between two groups′reducing extent of LDL-C is not statistically significant(P>0.05),treatment group is much better than control group. 4. The difference between two groups′reducing extent of WC is statistically significant (P<0.05),the difference between two groups′ reducing extent of BW is not statistically significant (P>0.05),the difference between two groups′reducing extent of BMI is significant (P<0.01),treatment group is better than control group. Conclusion Liver-invigorating and fat-reducing particles can relieve the nonalcoholic fatty liver disease,and relieve the insulin resistant. It can also reduce the level of ALT,AST,GGT,TG,TC,WC,BMI.